Pulmonary infection due to fluoroquinolone-resistant Mycolicibacterium fortuitum: a case report.
Kana KurokawaNorihiro HaradaHitoshi SasanoHaruhi TakagiSatomi TakeiAyako NakamuraKeisuke KamadaAtsushi YoshidaKen KikuchiKazuhisa TakahashiPublished in: BMC infectious diseases (2020)
This is the first report on the treatment of fluoroquinolone-resistant M. fortuitum and investigation of the mechanism of resistance. We suggest that the susceptibility test remains effective for determining the next line of treatment after a pathogen has acquired resistance, and resistance to fluoroquinolones in M. fortuitum can be attributed to a single change of amino acid.